Idexx Laboratories has announced the commercial launch of its Catalyst SDMA Test, for use in the diagnosis of kidney disease in dogs and cats, in North America.
The Catalyst SDMA Test can be added to any chemistry panel on Idexx's Catalyst One and Catalyst Dx chemistry analysers, and has been proven to identify kidney disease earlier than creatinine, delivering results in only a few minutes.
“Idexx Laboratories has launched its new Catalyst SDMA Test, for use in the diagnosis of kidney diseases in dogs and cats.“
This enables veterinarians to intervene as early as possible, with significant benefits for animals' quality of life. It has been available in research applications since 2015, with more than 4,500 pre-orders dispatched to North American customers prior to its commercial launch.
Idexx Laboratories also plans to introduce the Catalyst SDMA Test to customers beyond the US and Canada over the coming months, with more than 28,000 Catalyst One and Catalyst Dx analysers currently in use in veterinary practices worldwide.
Jonathan Ayers, chairman and chief executive officer of Idexx Laboratories, said: "We've seen great enthusiasm for the ability to run SDMA as part of the routine chemistry panel at the point of care, and pre-orders have exceeded our expectations."
With over 20 years of experience within the animal health market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current animal health roles we have available, you can search for the latest job roles, register your details, or contact the team today.See all the latest jobs in Animal Health